Korean J Pediatr.
2018 Feb;61(2):68-69. 10.3345/kjp.2018.61.2.68.
B-type natriuretic peptide may have a role in the management of patent ductus arteriosus
- Affiliations
-
- 1Department of Pediatrics, Ajou Univerisity School of Medicine, Suwon, Korea. neopedlee@gmail.com
- KMID: 2452044
- DOI: http://doi.org/10.3345/kjp.2018.61.2.68
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Applications of Plasma B-type Natriuretic Peptide Assays in Preterm Infants with Patent Ductus Arteriosus
- Nonsurgical closure of patent ductus arteriosus with the rashkind PDA occluder system
- Correlation of B-type natriuretic peptide levels and echocardiographic parameters in preterm infants with patent ductus arteriosus
- Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants
- Three Cases of Hemolysis After Transcatheter Closure of A Patent Ductus Arteriosus
